Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
About your search
CD2 and lymphoma are reported together in 3 articles.
Gene
CD2
- HGNC
- HGNC:1639
4articles
4mentions
0variants with confirmed gene link
Most co-reported phenotypes (articles)
Phenotype
Lymphoma
428articles
428mentions
12co-reported genes shown
Most co-reported genes (articles)
Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.
Publications
3 records shown · first 60Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.
PMID 31115909 | DOI 10.1111/bjh.15960 · British journal of haematology · 2019 · 4 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | CD2 | “Excepting definitional markers, there was a significant differential expression of the markers CD2, CD10, CD33 and TdT between ETP-ALL and non-ETP-ALL.” | 0.98 | hgnc_dict_v1 |
| phenotype | lymphoma | “Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.” | 0.98 | phenotype_alias_lexicon_v2 |
| gene | CD33 | “Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.” | 0.98 | hgnc_dict_v1 |
| phenotype | leukemia | “Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.” | 0.93 | phenotype_alias_lexicon_v2 |
Sinonasal T-Cell lymphomas: A clinicopathologic study of a possibly distinct entity.
PMID 17277464 | DOI 10.5144/0256-4947.1999.484 · Annals of Saudi medicine · 1999 · 2 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | CD2 | “BACKGROUND: Most cases of sinonasal lymphomas reported in the literature which show positive expression for Epstein-Barr virus are CD2+, CD3-, CD43+ and CD56+, and also show a germ-line T-cell receptor genotype.” | 0.98 | hgnc_dict_v1 |
| phenotype | lymphoma | “We report a group of patients with T-cell sinonasal lymphoma that showed distinct immunophenotypic and molecular profiles and a more aggressive behavior.” | 0.98 | phenotype_alias_lexicon_v2 |
Peripheral T-cell lymphoma with unique immunologic features.
PMID 8431865 | DOI 10.1002/1097-0142(19930201)71:3<831::aid-cncr2820710328>3.0.co;2-4 · Cancer · 1993 · 2 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | CD2 | “Expression or deficiency of CD2 and CD3 antigens on malignant T-cells did not show any difference in the AMLR assay.” | 0.98 | hgnc_dict_v1 |
| phenotype | lymphoma | “Peripheral T-cell lymphoma with unique immunologic features.” | 0.98 | phenotype_alias_lexicon_v2 |